Skip to main content

Advertisement

Log in

A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD)

  • Original Article
  • Published:
Metabolic Brain Disease Aims and scope Submit manuscript

Abstract

A metabonomics study based on GC/MS and multivariate statistical analysis was performed involving 28 post stroke depressed (PSD) patients, 27 post-stroke non-depressed (PSND) patients and 33 healthy subjects to investigate the biochemical perturbation in their plasma samples. The outcome of this study showed that there was distinctive metabolic profile for PSD patients. Seven sentinel metabolites showed marked perturbations in PSD patients' blood. The introduction of metabonomics approach may provide a novel metabonomic insight about PSD and the sentinel metabolites for classifying PSD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Adams HP Jr., Davis PH, Leira EC, Chang KC, Bendixen BH, Clarke WR, Woolson RF, Hansen MD (1999) Baseline NIH stroke scale score strongly predicts outcome after stroke: a report of the trial of Org 10172 in acute stroke treatment (TOAST). Neurology 53:126–131

    Article  CAS  PubMed  Google Scholar 

  • Arrieta-Cruz I, Su Y, Knight CM, Lam TK, Gutierrez-Juarez R (2013) Evidence for a role of proline and hypothalamic astrocytes in the regulation of glucose metabolism in rats. Diabetes 62:1152–1158

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Arvelo MB, Cooper JT, Longo C, Daniel S, Grey ST, Mahiou J, Czismadia E, Abu-Jawdeh G, Ferran C (2002) A20 protects mice from D-galactosamine/lipopolysaccharide acute toxic lethal hepatitis. Hepatology 35:535–543

    Article  CAS  PubMed  Google Scholar 

  • Belgardt BF, Bruning JC (2010) CNS leptin and insulin action in the control of energy homeostasis. Ann N Y Acad Sci 1212:97–113

    Article  CAS  PubMed  Google Scholar 

  • Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS (2011) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35:804–817

    Article  CAS  PubMed  Google Scholar 

  • Burvill PW, Johnson GA, Jamrozik KD, Anderson CS, Stewart-Wynne EG, Chakera TM (1995) Prevalence of depression after stroke: the perth community stroke study. Br J Psychiatry 166:320–327

    Article  CAS  PubMed  Google Scholar 

  • Corthesy-Theulaz I, den Dunnen JT, Ferre P, Geurts JM, Muller M, van Belzen N, van Ommen B (2005) Nutrigenomics: the impact of biomics technology on nutrition research. Ann Nutr Metab 49:355–365

    Article  CAS  PubMed  Google Scholar 

  • Coster J, McCauley R, Hall J (2004) Glutamine: metabolism and application in nutrition support. Asia Pac J Clin Nutr 13:25–31

    CAS  PubMed  Google Scholar 

  • Ding X, Yang S, Li W, Liu Y, Li Z, Zhang Y, Li L, Liu S (2014) The potential biomarker panels for identification of major depressive disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis. PLoS One 9:e97479

    Article  PubMed  PubMed Central  Google Scholar 

  • Ebert D, Haller RG, Walton ME (2003) Energy contribution of octanoate to intact rat brain metabolism measured by 13C nuclear magnetic resonance spectroscopy. J Neurosci 23:5928–5935

    CAS  PubMed  Google Scholar 

  • Feng B, Wu S, Lv S, Liu F, Chen H, Yan X, Li Y, Dong F, Wei L (2007) Metabolic profiling analysis of a D-galactosamine/lipopolysaccharide-induced mouse model of fulminant hepatic failure. J Proteome Res 6:2161–2167

    Article  CAS  PubMed  Google Scholar 

  • Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L (2000) Metabolite profiling for plant functional genomics. Nat Biotechnol 18:1157–1161

    Article  CAS  PubMed  Google Scholar 

  • First MB, Donovan S, Frances A (1996) Nosology of chronic mood disorders. Psychiatr Clin North Am 19:29–39

    Article  CAS  PubMed  Google Scholar 

  • Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG (2007) Free amino acid and dipeptide changes in the body fluids from alzheimer’s disease subjects. Amino Acids 32:213–224

    Article  CAS  PubMed  Google Scholar 

  • Gainotti G, Marra C (2002) Determinants and consequences of post-stroke depression. Curr Opin Neurol 15:85–89

    PubMed  Google Scholar 

  • Hagler L, Herman RH (1973) Oxalate metabolism. I. Am J Clin Nutr 26:758–765

    CAS  PubMed  Google Scholar 

  • Hawkins RA (2009) The blood-brain barrier and glutamate. Am J Clin Nutr 90:867S–874S

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hawkins RA, Simpson IA, Mokashi A, Vina JR (2006) Pyroglutamate stimulates Na + −dependent glutamate transport across the blood-brain barrier. FEBS Lett 580:4382–4386

  • Kauhanen M, Korpelainen JT, Hiltunen P, Brusin E, Mononen H, Maatta R, Nieminen P, Sotaniemi KA, Myllyla VV (1999) Poststroke depression correlates with cognitive impairment and neurological deficits. Stroke 30:1875–1880

    Article  CAS  PubMed  Google Scholar 

  • Khatri N, Man HY (2013) Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases. Front Neurol 4:199

    Article  PubMed  PubMed Central  Google Scholar 

  • Krishnan E (2010) Inflammation, oxidative stress and lipids: the risk triad for atherosclerosis in gout. Rheumatology (Oxford) 49:1229–1238

    Article  CAS  Google Scholar 

  • Li W, Ling S, Yang Y, Hu Z, Davies H, Fang M (2014) Systematic hypothesis for post-stroke depression caused inflammation and neurotransmission and resultant on possible treatments. Neuro Endocrinol Lett 35:104–109

    PubMed  Google Scholar 

  • Maes M, Mihaylova I, Kubera M, Ringel K (2012) Activation of cell-mediated immunity in depression: association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression. Prog Neuro-Psychopharmacol Biol Psychiatry 36:169–175

    Article  Google Scholar 

  • Milhavet O, McMahon HE, Rachidi W, Nishida N, Katamine S, Mange A, Arlotto M, Casanova D, Riondel J, Favier A, Lehmann S (2000) Prion infection impairs the cellular response to oxidative stress. Proc Natl Acad Sci U S A 97:13937–13942

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Morris PL, Robinson RG, Raphael B (1993) Emotional lability after stroke. Aust N Z J Psychiatry 27:601–605

    Article  CAS  PubMed  Google Scholar 

  • Panov A, Orynbayeva Z, Vavilin V, Lyakhovich V (2014) Fatty acids in energy metabolism of the central nervous system. Biomed Res Int 2014:472459

    Article  PubMed  PubMed Central  Google Scholar 

  • Paradiso S, Ohkubo T, Robinson RG (1997) Vegetative and psychological symptoms associated with depressed mood over the first two years after stroke. Int J Psychiatry Med 27:137–157

    Article  CAS  PubMed  Google Scholar 

  • Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM (2013) Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun 31:143–152

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rezzi S, Ramadan Z, Fay LB, Kochhar S (2007) Nutritional metabonomics: applications and perspectives. J Proteome Res 6:513–525

    Article  CAS  PubMed  Google Scholar 

  • Rho HS, Ghimeray AK, Yoo DS, Ahn SM, Kwon SS, Lee KH, Cho DH, Cho JY (2011) Kaempferol and kaempferol rhamnosides with depigmenting and anti-inflammatory properties. Molecules 16:3338–3344

    Article  CAS  PubMed  Google Scholar 

  • Sasaki M, Ohara-Nemoto Y, Tajika S, Kobayashi M, Yamaura C, Kimura S (2001) Antigenic characterisation of a novel streptococcus anginosus antigen that induces nitric oxide synthesis by murine peritoneal exudate cells. J Med Microbiol 50:952–958

    Article  CAS  PubMed  Google Scholar 

  • Schmidtke A, Fleckenstein P, Moises W, Beckmann H (1988) Studies of the reliability and validity of the German version of the montgomery-asberg depression rating scale (MADRS). Schweiz Arch Neurol Psychiatr 139:51–65

    CAS  PubMed  Google Scholar 

  • Schubert DS, Taylor C, Lee S, Mentari A, Tamaklo W (1992) Physical consequences of depression in the stroke patient. Gen Hosp Psychiatry 14:69–76

    Article  CAS  PubMed  Google Scholar 

  • Schwab JJ, Bialow MR, Clemmons RS, Holzer CE (1967) Hamilton rating scale for depression with medical in-patients. Br J Psychiatry 113:83–88

    Article  CAS  PubMed  Google Scholar 

  • Schwartz MW, Woods SC, Porte D Jr., Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661–671

    CAS  PubMed  Google Scholar 

  • Shah S, Vanclay F, Cooper B (1989) Improving the sensitivity of the barthel index for stroke rehabilitation. J Clin Epidemiol 42:703–709

    Article  CAS  PubMed  Google Scholar 

  • Sinyor D, Amato P, Kaloupek DG, Becker R, Goldenberg M, Coopersmith H (1986) Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke 17:1102–1107

    Article  CAS  PubMed  Google Scholar 

  • Starkstein SE, Robinson RG (1989) Affective disorders and cerebral vascular disease. Br J Psychiatry 154:170–182

    Article  CAS  PubMed  Google Scholar 

  • Sun B, Wu S, Li L, Li H, Zhang Q, Chen H, Li F, Dong F, Yan X (2009) A metabolomic analysis of the toxicity of aconitum sp. alkaloids in rats using gas chromatography/mass spectrometry. Rapid Commun Mass Spectrom 23:1221–1228

    Article  CAS  PubMed  Google Scholar 

  • Tobe EH (2013) Mitochondrial dysfunction, oxidative stress, and major depressive disorder. Neuropsychiatr Dis Treat 9:567–573

    Article  PubMed  PubMed Central  Google Scholar 

  • Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922–935

    Article  CAS  PubMed  Google Scholar 

  • Toso V, Gandolfo C, Paolucci S, Provinciali L, Torta R, Grassivaro N (2004) Post-stroke depression: research methodology of a large multicentre observational study (DESTRO). Neurol Sci 25:138–144

    Article  CAS  PubMed  Google Scholar 

  • van der Greef J, Stroobant P, van der Heijden R (2004) The role of analytical sciences in medical systems biology. Curr Opin Chem Biol 8:559–565

    Article  PubMed  Google Scholar 

  • van Ommen B, Stierum R (2002) Nutrigenomics: exploiting systems biology in the nutrition and health arena. Curr Opin Biotechnol 13:517–521

    Article  PubMed  Google Scholar 

  • Williams LS, Jones WJ, Shen J, Robinson RL, Kroenke K (2004) Outcomes of newly referred neurology outpatients with depression and pain. Neurology 63:674–677

    Article  CAS  PubMed  Google Scholar 

  • Wu S, Zhou F, Zhang Z, Xing D (2011) Mitochondrial oxidative stress causes mitochondrial fragmentation via differential modulation of mitochondrial fission-fusion proteins. Febs j 278:941–954

    Article  CAS  PubMed  Google Scholar 

  • Xie G, Schepetkin IA, Quinn MT (2007) Immunomodulatory activity of acidic polysaccharides isolated from tanacetum vulgare L. Int Immunopharmacol 7:1639–1650

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang F, Jia Z, Gao P, Kong H, Li X, Lu X, Wu Y, Xu G (2010) Metabonomics study of urine and plasma in depression and excess fatigue rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry. Mol BioSyst 6:852–861

    Article  CAS  PubMed  Google Scholar 

  • Zheng P, Gao HC, Li Q, Shao WH, Zhang ML, Cheng K, de Yang Y, Fan SH, Chen L, Fang L, Xie P (2012) Plasma metabonomics as a novel diagnostic approach for major depressive disorder. J Proteome Res 11:1741–1748

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank all participants who took part in this study, and the experts at the National Center of Biomedical Analysis for providing technical assistant. This work was supported by the Chinese National Key Project of Basic Research (2009CB918301 and 2009CB918303) and the Chinese National Natural Science Foundation (81370051 and 81471155).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Shuguang Yang, Jing Liu, Bo Xiao or Shaojun Liu.

Ethics declarations

Conflict of interest

The authors have declared no conflict of interest.

Additional information

Xinghua Ding, Ruoxu Liu and Wenkai Li contributed equally to this work.

Electronic supplementary material

Figure S1

The GC/TOF-MS TICs of healthy subjects, PSD patients, and PSND patients. The GC/TOF-MS total ion current chromatograms (TICs) of healthy subjects' group (a), PSD (b), and PSND (c). Each peaks of TICs represented the endogenous metabolites in plasma. PSD indicates Post-stroke depression patients group, PSND indicates Post-stroke non-depression patients group. (GIF 27.7 kb)

High Resolution Image (EPS 1.75 mb)

Table S1

RPA of metabolites detected by GC/MS in human plasma A. A, The normalized intensities of metabolites in healthy control subjects, Post-stroke patients including Post-stroke depression patients (PSD) and Post-stroke non-depression patients (PSND) are expressed with their Relative peak areas (RPA). Values are presented as mean ± SD. VIPB shows variable importance in the projection obtained from the PLS-DA model with a cutoff of 1.0. a, shows VIP value and P value (Student’s t-test or Mann-whitney test) between the healthy control subjects and Post-stroke patients; b, shows VIP value and P value between the PSD patients and PSND patients. (DOCX 28.8 kb)

Table S2

RPA of sentinel metabolites among the healthy subjects' group, post-stroke patients' group and its subgroup (PSD patients and PSND patients) from test set A. A, The normalized intensities of metabolites in healthy subjects, Post-stroke patients including Post-stroke depression patients (PSD) and Post-stroke non-depression patients (PSND) are expressed with their Relative peak areas (RPA). Values are presented as mean ± SD. a, shows P value obtained from the univariate analysis between the healthy control subjects and Post-stroke patients; b, shows P value between the PSD patients and PSND patients. (DOCX 16.4 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ding, X., Liu, R., Li, W. et al. A metabonomic investigation on the biochemical perturbation in post-stroke patients with depressive disorder (PSD). Metab Brain Dis 31, 279–287 (2016). https://doi.org/10.1007/s11011-015-9748-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11011-015-9748-z

Keywords

Navigation